1. Next-Gen Drug Development

IND/IDE Acceleration: Mechanistic MOA validation → GLP tox packages

Smart ADME/PK-PD: AI-powered PBPK modeling & microdosing predictions

Global Compliance: ICH-aligned protocols for US/EU/APAC submissions

2. Medical Device Breakthroughs

Surgical Mastery: 95% success rate in porcine/canine/NHP models (ECMO, artificial hearts)

MDR 2024-Ready: Full Annex XIV testing (ISO 10993 biocompatibility, cybersecurity)

Digital Twins: VR-enhanced device implantation simulations

3. Translational Edge

CRISPR-Edited Models: 200+ disease-specific large animal platforms

Biomarker Hunting: ML-driven discovery with 92% clinical correlation

Path to Partnership Consult:Free regulatory roadmap session (60 mins)

Design:AI-optimized protocol in 72h

Execute:Real-time dashboards & milestone alerts

Submit:Globally compliant reports

Headquartered in Guangzhou, HuaTeng Biotechnology redefines preclinical excellence through OECD GLP-certified platforms and AAALAC-accredited translational models. Since 2019, we've become the strategic partner of choice for 2000+ biopharma challengers and MedTech pioneers across 10 countries, delivering:

☑ 85% first-cycle FDA/EMA/MDR approval rates

☑ 40% cost reduction via AI-driven study design and Asia-EU parallel testing

☑ 6-month faster timelines for Class III implants & orphan drug development

Copyright ©️ 2022, NetEase Zhuyou(and its affiliates as applicable). All Rights Reserved.

Building 11-12, Block B, Lian Dong U Valley, No.29, Bishan Street, Huangpu District, Guangzhou China

Room 503, 5/F Hang Seng Castle Peak Road Building 339 Castle Peak Road Cheung Sha Wan Hong Kong

Home

LinkedIn

Preclinical Drug Development Solutions

Facebook

Twitter

Medical Device Testing In Vivo

Laboratory Sciences